Company

AOXING PHARMACEUTICAL COMPANY, INC. (0001060426)

Standardized SEC financial data for AOXING PHARMACEUTICAL COMPANY, INC. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001060426 · Pharmaceutical Preparations.

Gross margin

76.0%

Operating margin

19.3%

Net margin

6.4%

Revenue growth (YoY)

26.9%

Return on equity

11.4%

ROIC

17.1%

Free cash flow

-$653K

Debt / equity

0.56×

Ratios for fiscal year 2016, standardized from SEC filings.

Income statement

USD	FY2016
Revenue	$32.3M
Cost of revenue	$7.8M
Gross profit	$24.6M
R&D expense	$3.1M
SG&A expense	$11.6M
Operating income	$6.2M
EBITDA	$7.3M
Interest expense	$2.4M
Pretax income	$2.9M

Balance sheet

USD	FY2016
Inventory	$2.8M
Total current assets	$26.9M
Property, plant & equipment	$25.6M
Total assets	$56.2M
Total current liabilities	$37.8M
Total liabilities	$37.1M
Retained earnings	-$56.3M
Total equity	$19.1M

Cash flow

USD	FY2016
Operating cash flow	-$535K
Capital expenditures	$118K
Free cash flow	-$653K
Investing cash flow	-$118K
Financing cash flow	$2.9M
Dividends paid	$0

Get 0001060426 data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001060426/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001060426/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View 0001060426 filings on SEC EDGAR →